RICE HALL JAMES & ASSOCIATES, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001230765

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q1 2026 · 243 positions · Total reported value $1.80B · Top-10 concentration 23.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 77.5% · 9 new · 172 cut · 12 exited

Active Share (vs S&P 500): 98.5% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.7% · vs SPY -6.9% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.1% · vs SPY +3.0% · Latest Value $1.89B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, RICE HALL JAMES & ASSOCIATES, LLC disclosed 243 equity positions with a combined reported value of $1.80B. The filing implies a diversified portfolio: its ten largest positions account for 23.9% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q1 2026 were LGND ($56.61M), FN ($55.18M), ARLO ($52.08M). By sector, the heaviest allocations are Health Care 28.6%, Consumer Discretionary 26.8%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+1.4pp), Technology (+1.3pp) and away from Health Care (-1.2pp), Other (-2.7pp).

Versus the prior quarter, RICE HALL JAMES & ASSOCIATES, LLC opened 9 new positions, trimmed 172 and fully exited 12, a turnover rate of 77.5% of positions. The portfolio's overlap with the prior quarter was 91% of names.

The largest new positions opened in Q1 2026 were UPWK ($14.34M), SLNO ($6.90M), TCBK ($4.53M).

Of the 12 positions fully exited versus the prior quarter, the largest were IWC ($4.53M), IWM ($4.28M), CWAN ($1.47M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • UPWK UPWORK INC · $14.34M
  • SLNO SOLENO THERAPEUTICS INC · $6.90M
  • TCBK TRICO BANCSHARES · $4.53M
  • ODD ODDITY TECH LTD · $3.53M
  • OLED UNIVERSAL DISPLAY CORP · $1.99M
  • XERS XERIS BIOPHARMA HOLDINGS INC · $1.46M
  • ALKT ALKAMI TECHNOLOGY INC · $1.01M
  • ATRC ATRICURE INC · $719.24K

Fully Exited (vs previous quarter)

  • IWC iShares Russell Micro-Cap ETF · prev qtr: $4.53M
  • IWM ISHARES TR · prev qtr: $4.28M
  • CWAN CLEARWATER ANALYTICS HLDGS I · prev qtr: $1.47M
  • CODA CODA OCTOPUS GROUP INC · prev qtr: $1.13M
  • INSM INSMED INC · prev qtr: $789.45K
  • SNWV SANUWAVE HEALTH INC · prev qtr: $750.65K
  • DENN DENNYS CORP · prev qtr: $558.93K
  • DLB DOLBY LABORATORIES INC · prev qtr: $314.10K

Insider Transactions (Form 4)

Latest RICE HALL JAMES & ASSOCIATES, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rice Hall James & Associates, based in San Diego, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 240 positions worth $2.05B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN DIEGO, CA, United States
  • SEC registration: 801-61905 (status: Approved), registered 2003-02-13
  • Regulatory AUM (Form ADV): $1.74B as of 2026-05-06
  • Client mix (by RAUM): pension and profit-sharing plans 62%, individual investors 30%
  • Website: ricehalljames.com

Portfolio Structure

  • 240 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 24.1% of reported value
  • Largest position: LGND (LIGAND PHARMACEUTICALS INC) at 4.2%
  • Average position size: $8.56M

Sector Tilt

  • Health Care 31.6%
  • Consumer Discretionary 25.0%
  • Information Technology 20.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 12 new, 94 added, 97 reduced, 15 exited
  • 37 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 28.6%
Technology 20.3%
Financials 3.6%
Utilities 3.2%
Other 6.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 283.57K $56.61M 3.15%
3.15%
Add
2 105.81K $55.18M 3.07%
3.07%
Reduce
3 3.66M $52.08M 2.90%
2.90%
Add
4 224.30K $43.64M 2.43%
2.43%
Add
5 1.00M $41.15M 2.29%
2.29%
Add
6 438.44K $38.66M 2.15%
2.15%
Add
7 847.73K $37.07M 2.06%
2.06%
Add
8 780.04K $36.77M 2.05%
2.05%
Add
9 148.39K $33.94M 1.89%
1.89%
Add
10 799.82K $33.56M 1.87%
1.87%
Add
11 548.67K $31.15M 1.74%
1.74%
Reduce
12 521.62K $30.92M 1.72%
1.72%
Add
13 608.42K $29.30M 1.63%
1.63%
Add
14 176.86K $29.15M 1.62%
1.62%
Add
15 577.08K $27.94M 1.56%
1.56%
Reduce
16 180.31K $27.60M 1.54%
1.54%
Add
17 296.79K $26.73M 1.49%
1.49%
Add
18 1.58M $26.49M 1.48%
1.48%
Add
19 319.45K $26.41M 1.47%
1.47%
Add
20 704.12K $26.23M 1.46%
1.46%
Add
21 531.85K $26.07M 1.45%
1.45%
Add
22 53.98K $25.92M 1.44%
1.44%
Reduce
23 477.42K $24.68M 1.37%
1.37%
Add
24 345.14K $24.58M 1.37%
1.37%
Add
25 2.23M $21.23M 1.18%
1.18%
Add
26 590.37K $21.15M 1.18%
1.18%
Add
27 184.72K $20.17M 1.12%
1.12%
Add
28 685.15K $20.12M 1.12%
1.12%
Add
29 597.24K $18.26M 1.02%
1.02%
Add
30 683.26K $17.98M 1.00%
1.00%
Add
31 898.61K $17.58M 0.98%
0.98%
Add
32 114.70K $17.02M 0.95%
0.95%
Add
33 1.03M $16.86M 0.94%
0.94%
Add
34 241.99K $16.06M 0.89%
0.89%
Add
35 238.14K $15.54M 0.86%
0.86%
Add
36 72.75K $15.04M 0.84%
0.84%
Reduce
37 116.79K $14.99M 0.83%
0.83%
Add
38 1.31M $14.34M 0.80%
0.80%
New
39 222.92K $14.29M 0.80%
0.80%
Add
40 2.12M $13.81M 0.77%
0.77%
Add
41 390.34K $13.80M 0.77%
0.77%
Add
42 617.49K $13.75M 0.77%
0.77%
Add
43 147.04K $13.58M 0.76%
0.76%
Reduce
44 1.27M $13.53M 0.75%
0.75%
Add
45 99.99K $13.17M 0.73%
0.73%
Add
46 368.18K $12.98M 0.72%
0.72%
Add
47 105.34K $12.96M 0.72%
0.72%
Add
48 75.38K $12.20M 0.68%
0.68%
Add
49 733.66K $12.19M 0.68%
0.68%
Add
50 259.59K $11.91M 0.66%
0.66%
Add

FAQ

What did RICE HALL JAMES & ASSOCIATES, LLC buy in 2026-Q1?

In its 2026-Q1 13F filing, RICE HALL JAMES & ASSOCIATES, LLC reported 243 equity positions worth $1.80B in aggregate; its largest disclosed positions were LGND ($56.61M), FN ($55.18M), ARLO ($52.08M).

How large is RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

RICE HALL JAMES & ASSOCIATES, LLC reported $1.80B of long equity holdings across 243 positions as of 2026-Q1. Top-10 holdings account for 23.9% of reported value.

What is RICE HALL JAMES & ASSOCIATES, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rice-hall-james-and-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →